These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8618897)

  • 1. Differentiation of immortal cells inhibits telomerase activity.
    Sharma HW; Sokoloski JA; Perez JR; Maltese JY; Sartorelli AC; Stein CA; Nichols G; Khaled Z; Telang NT; Narayanan R
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12343-6. PubMed ID: 8618897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines.
    Bestilny LJ; Brown CB; Miura Y; Robertson LD; Riabowol KT
    Cancer Res; 1996 Aug; 56(16):3796-802. PubMed ID: 8706026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere reduction and telomerase inactivation during neuronal cell differentiation.
    Kruk PA; Balajee AS; Rao KS; Bohr VA
    Biochem Biophys Res Commun; 1996 Jul; 224(2):487-92. PubMed ID: 8702416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein.
    Reichman TW; Albanell J; Wang X; Moore MA; Studzinski GP
    J Cell Biochem; 1997 Oct; 67(1):13-23. PubMed ID: 9328835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
    Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
    Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of telomerase activity is an early event of cellular differentiation without apparent telomeric DNA change.
    Yamada O; Takanashi M; Ujihara M; Mizoguchi H
    Leuk Res; 1998 Aug; 22(8):711-7. PubMed ID: 9680098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes.
    Mollinedo F; Gajate C; Tugores A; Flores I; Naranjo JR
    Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):137-44. PubMed ID: 8363564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of glutathione on HL-60 treated with dimethylsulfoxide, butyric acid or 12-O-tetradecanoylphorbol-13-acetate.
    Zucker RM; Whittington KB; Decal DL
    FEBS Lett; 1983 May; 155(1):107-12. PubMed ID: 6573264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss and reappearance of transferrin receptors in human leukemic cell lines.
    Petraki H; Ioannides CG; Filli S; Papamichail M
    Exp Cell Biol; 1986; 54(2):80-8. PubMed ID: 3011533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of differentiation of mouse myeloid leukemia M1 cells by serum of patients with chronic myeloid leukemia.
    Okabe-Kado J; Honma Y; Hayashi M; Hozumi M; Sampi K; Sakurai M; Hino K; Tsuruoka N
    Jpn J Cancer Res; 1988 Dec; 79(12):1318-26. PubMed ID: 3148602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications.
    Koeffler HP
    Blood; 1983 Oct; 62(4):709-21. PubMed ID: 6192859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supression of telomerase activity in HL60 cells after treatment with differentiating agents.
    Xu D; Gruber A; Peterson C; Pisa P
    Leukemia; 1996 Aug; 10(8):1354-7. PubMed ID: 8709642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multistep regulation of telomerase during differentiation of HL60 cells.
    Yamada O; Ozaki K; Nakatake M; Akiyama M; Kawauchi K; Matsuoka R
    J Leukoc Biol; 2008 May; 83(5):1240-8. PubMed ID: 18276798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialic acid lyase in human promyelocytic leukemic cells (HL-60) during phorbol-ester-induced differentiation.
    Warren L
    Biochim Biophys Acta; 1986 Oct; 888(3):278-81. PubMed ID: 3463364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of telomerase activity in immortal cell lines.
    Holt SE; Wright WE; Shay JW
    Mol Cell Biol; 1996 Jun; 16(6):2932-9. PubMed ID: 8649404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DMSO, sodium butyrate, and TPA induce hypophosphorylation of RB with HL-60 cell differentiation.
    Yen A; Varvayanis S
    In Vitro Cell Dev Biol Anim; 1995 Mar; 31(3):164-7. PubMed ID: 7757295
    [No Abstract]   [Full Text] [Related]  

  • 17. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines.
    Albanell J; Han W; Mellado B; Gunawardane R; Scher HI; Dmitrovsky E; Moore MA
    Cancer Res; 1996 Apr; 56(7):1503-8. PubMed ID: 8603393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of TERA-2 human embryonal carcinoma cells into neurons and HCMV permissive cells. Induction by agents other than retinoic acid.
    Andrews PW; Gönczöl E; Plotkin SA; Dignazio M; Oosterhuis JW
    Differentiation; 1986; 31(2):119-26. PubMed ID: 3017799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All trans-retinoic acid suppresses in vitro growth and down-regulates LIF gene expression as well as telomerase activity of human medulloblastoma cells.
    Liu J; Guo L; Luo Y; Li JW; Li H
    Anticancer Res; 2000; 20(4):2659-64. PubMed ID: 10953340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profile of the putative catalytic subunit of the telomerase gene.
    Ramakrishnan S; Eppenberger U; Mueller H; Shinkai Y; Narayanan R
    Cancer Res; 1998 Feb; 58(4):622-5. PubMed ID: 9485011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.